Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation
- Conditions
- Sepsis
- Interventions
- Other: Determined by intended physician
- Registration Number
- NCT01362829
- Lead Sponsor
- National Taiwan University Hospital
- Brief Summary
The investigators perform a prospective observation study to search for the outcome predictors (ScvO2 and lactate) in patients with severe sepsis after admission to ICU.
- Detailed Description
Early goal-directed therapy in patients with severe sepsis or septic shock was found to provide survival benefit.It was thought that early optimization of ScvO2 within 6 hours in emergency department brought survival benefit to patients of septic shock or severe sepsis.On the other hand, early lactate clearance is associated with improved outcome in patients with severe sepsis or septic shock. In patients with severe sepsis and septic shock, those with low lactate clearance had poor prognosis, despite optimization of ScvO2. It is unknown if ScvO2 could still guide hemodynamic resuscitation after admission into ICU. The investigators perform a prospective observation study to see the correlation between ScvO2 and clinical outcome (including organ failure, disease severity, and survival) and the correlation between lactate and clinical outcome. Furthermore, if ScvO2 \>= 70% is still of prognostic significance in ICU, we will investigate the outcome in patients with high ScvO2 and high serum lactate levels, and to evaluate the clinical features of this patient population.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
- Adult patients who are admitted to medical intensive care units with severe sepsis or septic shock
-
Patients would be excluded if they have any one of the exclusion criteria, *including pregnancy
- presence of acute cerebral vascular attack
- acute cardiogenic lung edema
- status asthmatics
- cardiac dysrhythmia as the primary diagnosis
- massive gastrointestinal bleeding
- epileptics
- drug overdose
- requirement of immediate surgery
- hematologic malignancies
- febrile neutropenia
- treatment with immunosuppressive agents before admission
- advanced malignancy and poor pre-admission performance status
- with inevitable short-term mortality or morbidity
- HIV infection
- refusal of consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with severe sepsis Determined by intended physician Patients who are admitted to medical ICU with severe sepsis
- Primary Outcome Measures
Name Time Method 28-day Mortality 28 days Record 28-day all-cause mortality in each population (low ScvO2, high ScvO2 and low serum lactate, high ScvO2 and high serum lactate)
- Secondary Outcome Measures
Name Time Method Severity of organ failure 1 week To evaluate the development of ARDS/ALI, AKI, and the record the SOFA score
In-Hospital Mortality 2 months Participants will be followed for the duration of hospital stay, an expected average of 2 months
Trial Locations
- Locations (2)
Far Eastern Memorial Hospital
🇨🇳Taipei, Taiwan
National Taiwan University Hospital
🇨🇳Taipei, Taiwan